US53228F1012
US53228F1012
LifeStance Health Group, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 4.72B EUR | 4.09B EUR | 2.47B EUR | 2.73B EUR |
Enterprise Value | 4.86B EUR | 4.33B EUR | 2.73B EUR | 2.96B EUR |
Valuation Multiples | ||||
Trailing P/E | 95.54x | 80.86x | 106.5x | 305.31x |
Forward P/E | 28.83x | -- | -- | -- |
Price to Sales | 2.98x | 2.58x | 1.65x | 2.51x |
Price to Book | 3.21x | 2.77x | 1.67x | 1.8x |
EV/Revenue | 3.06x | 2.73x | 1.83x | 2.71x |
EV/EBITDA | 35.97x | 32.6x | 27.66x | 46.67x |
Price to FCF (P/FCF) | 27.39x | 23.53x | 17.32x | 22.73x |
EV/FCF | 28.17x | 24.87x | 19.17x | 24.61x |
FCF Yield | 3.65% | 4.25% | 5.77% | 4.4% |